How can genetic analysis be used to determine chronic lymphocytic leukemia (CLL) treatment?
The latest data in diffuse large B-cell lymphoma from ICML 2017
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
The standard of care for DLBCL and double-hit lymphoma
Why we need novel strategies for diffuse large B-cell lymphoma